Takeshi Yamamoto

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial

Wataru Shimizu, Yoshiaki Kubota, Yu Hoshika et al. · Cardiovascular Diabetology · 2020 · 223 citations · Full text

Characterization of predictors of in-hospital cardiac complications of takotsubo cardiomyopathy: Multi-center registry from Tokyo CCU Network

Tsutomu Murakami, Tsutomu Yoshikawa, Yuichiro Maekawa et al. · Journal of Cardiology · 2013 · 89 citations · Full text

Cardiomyopathy, Heart Failure, Takotsubo Cardiomyopathy +11

Gender Differences in Patients with Takotsubo Cardiomyopathy: Multi-Center Registry from Tokyo CCU Network

Tsutomu Murakami, Tsutomu Yoshikawa, Yuichiro Maekawa et al. · PLoS ONE · 2015 · 88 citations · Full text

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

A Rapid Bedside D-Dimer Assay (Cardiac D-Dimer) for Screening of Clinically Suspected Acute Aortic Dissection

Koichi Akutsu, Naoki Sato, Takeshi Yamamoto et al. · Circulation Journal · 2005 · 87 citations · Full text